THE IMPACT OF EXERCISE AND CALORIC RESTRICTION ON CANCER RECURRENCE IN MICE

运动和热量限制对小鼠癌症复发的影响

基本信息

  • 批准号:
    8072521
  • 负责人:
  • 金额:
    $ 34.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-24 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

Understanding the biological mechanisms that underlie the anti-tumorigenic effects of calorie restriction and physical activity will likely be essential for translating laboratory advances in this field to the development of more effective strategies for preventing cancer in humans. The goal of Project 1 ofthe Penn TREC Survivor Center is to advance our understanding of the impact of energetics on breast cancer recurrence. Project 1 will use an innovative genetically engineered mouse model for breast cancer recurrence developed at Penn to determine the effects of exercise, calorie restriction, or their combination on breast cancer recurrence. Mammary tumors will be induced in oven/veight mice by the doxycycline-dependent activation of an oncogene relevant to human breast cancer in the mammary glands of mice fed a high fat diet. Regression of the resulting tumors will be induced by oncogene down-regulation to generate cohorts of mice bearing dormant residual tumor cells. Overweight mice bearing residual disease will be randomly assigned to exercise, calorie restriction, both of these interventions, or neither and followed for cancer recurrence. Biomarkers will be evaluated to explore the hypothesized relationship between energy balance and recurrence and will include markers reflecting the PI3K-Akt-mT0R pathway, insulin resistance, IGF-1, HGF, adipokines, inflammation, tumor angiogenesis and oxidative stress. To our knowledge, this study will be the first to explore the impact of exercise and calorie restriction on cancer recurrence in an animal model. The studies proposed in Project 1 build on the unique combination of strengths and expertise in cancer biology, obesity, endocrinology, and exercise physiology among researchers in the proposed Penn TREC Survivor Center. In addition, the design of this study closely parallels an analogous human trial proposed in Project 2. The assembled team of investigators will work jointly to create new experimental paradigms that integrate and move beyond discipline-specific approaches to address the role of energy balance in breast cancer recurrence. In doing so, this project will advance the mission ofthe Penn TREC Survivor center to promote transdisciplinary, translational science on energy balance and cancer survivorship.
了解卡路里限制和体力活动的抗肿瘤作用的生物学机制可能对于将该领域的实验室进展转化为更有效的预防人类癌症的策略至关重要。宾夕法尼亚TREC幸存者中心的项目1的目标是促进我们对能量学对乳腺癌复发的影响的理解。项目1将使用宾夕法尼亚大学开发的乳腺癌复发的创新基因工程小鼠模型,以确定运动,卡路里限制或其组合对乳腺癌复发的影响。 通过高脂饮食喂养的小鼠乳腺中与人乳腺癌相关的癌基因的多西环素依赖性激活,在oven/veight小鼠中诱导乳腺肿瘤。将通过癌基因下调诱导所得肿瘤的消退,以产生携带休眠残余肿瘤细胞的小鼠群。携带残留疾病的超重小鼠将被随机分配到运动、热量限制、这两种干预或都不进行,并跟踪癌症复发。 将评价生物标志物以探索能量平衡与复发之间的假设关系,并将包括反映PI 3 K-Akt-mT 0 R通路、胰岛素抵抗、IGF-1、HGF、脂肪因子、炎症、肿瘤血管生成和氧化应激的标志物。据我们所知,这项研究将是第一个在动物模型中探索运动和热量限制对癌症复发的影响。项目1中提出的研究建立在拟议的Penn TREC幸存者中心研究人员在癌症生物学,肥胖,内分泌学和运动生理学方面的优势和专业知识的独特组合之上。此外,本研究的设计与项目2中提出的类似人体试验密切相似。 集合的研究团队将共同努力,创造新的实验范式,整合并超越特定学科的方法,以解决能量平衡在乳腺癌复发中的作用。在这样做的过程中,该项目将推进宾夕法尼亚TREC幸存者中心的使命,以促进能量平衡和癌症生存的跨学科,转化科学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LEWIS A CHODOSH其他文献

LEWIS A CHODOSH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LEWIS A CHODOSH', 18)}}的其他基金

Radiogenomic Biomarkers of Breast Cancer Recurrence
乳腺癌复发的放射基因组生物标志物
  • 批准号:
    10161749
  • 财政年份:
    2018
  • 资助金额:
    $ 34.67万
  • 项目类别:
Radiogenomic Biomarkers of Breast Cancer Recurrence
乳腺癌复发的放射基因组生物标志物
  • 批准号:
    10403957
  • 财政年份:
    2018
  • 资助金额:
    $ 34.67万
  • 项目类别:
Secondary Prevention through Surveillance and Intervention
通过监测和干预进行二级预防
  • 批准号:
    9399635
  • 财政年份:
    2016
  • 资助金额:
    $ 34.67万
  • 项目类别:
Secondary Prevention through Surveillance and Intervention
通过监测和干预进行二级预防
  • 批准号:
    10051407
  • 财政年份:
    2016
  • 资助金额:
    $ 34.67万
  • 项目类别:
Novel PET imaging agents for understanding glutamine addiction in cancer
用于了解癌症中谷氨酰胺成瘾的新型 PET 成像剂
  • 批准号:
    8334480
  • 财政年份:
    2011
  • 资助金额:
    $ 34.67万
  • 项目类别:
Novel PET imaging agents for understanding glutamine addiction in cancer
用于了解癌症中谷氨酰胺成瘾的新型 PET 成像剂
  • 批准号:
    8546312
  • 财政年份:
    2011
  • 资助金额:
    $ 34.67万
  • 项目类别:
Developmental Research Core
发展研究核心
  • 批准号:
    8073250
  • 财政年份:
    2011
  • 资助金额:
    $ 34.67万
  • 项目类别:
Novel PET imaging agents for understanding glutamine addiction in cancer
用于了解癌症中谷氨酰胺成瘾的新型 PET 成像剂
  • 批准号:
    8231824
  • 财政年份:
    2011
  • 资助金额:
    $ 34.67万
  • 项目类别:
Novel PET imaging agents for understanding glutamine addiction in cancer
用于了解癌症中谷氨酰胺成瘾的新型 PET 成像剂
  • 批准号:
    8899339
  • 财政年份:
    2011
  • 资助金额:
    $ 34.67万
  • 项目类别:
Novel PET imaging agents for understanding glutamine addiction in cancer
用于了解癌症中谷氨酰胺成瘾的新型 PET 成像剂
  • 批准号:
    8733625
  • 财政年份:
    2011
  • 资助金额:
    $ 34.67万
  • 项目类别:

相似海外基金

Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 34.67万
  • 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
  • 批准号:
    494901
  • 财政年份:
    2023
  • 资助金额:
    $ 34.67万
  • 项目类别:
    Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
  • 批准号:
    10714537
  • 财政年份:
    2023
  • 资助金额:
    $ 34.67万
  • 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
  • 批准号:
    10588103
  • 财政年份:
    2023
  • 资助金额:
    $ 34.67万
  • 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
  • 批准号:
    22K09407
  • 财政年份:
    2022
  • 资助金额:
    $ 34.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
  • 批准号:
    21KK0287
  • 财政年份:
    2022
  • 资助金额:
    $ 34.67万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
  • 批准号:
    10357120
  • 财政年份:
    2022
  • 资助金额:
    $ 34.67万
  • 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
  • 批准号:
    21K08700
  • 财政年份:
    2021
  • 资助金额:
    $ 34.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
  • 批准号:
    437315
  • 财政年份:
    2020
  • 资助金额:
    $ 34.67万
  • 项目类别:
    Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
  • 批准号:
    435603
  • 财政年份:
    2020
  • 资助金额:
    $ 34.67万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了